Načítá se...
Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori
Helicobacter pylori (H. pylori) is a life-threatening pathogen which causes chronic gastritis, gastric ulcers and even stomach cancer. Treatment normally involves bacterial eradication; however, this type of treatment only has a rate of effectiveness of <80%. Thus, it is a matter of some urgency...
Uloženo v:
| Vydáno v: | Int J Mol Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501646/ https://ncbi.nlm.nih.gov/pubmed/26080893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2015.2251 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|